Research-for-Cure Academy

Jamile Ballivian

Nationality: Argentinian
Institution: Helios Salud
Country of work: Argentina

What is your motivation for engaging in HIV cure and remission research?

My main motivation is to continue improving the quality of life of people living with HIV. While the treatments available are effective and allow for a good quality of life, the possibility of cure remains a constant question when talking to patients. Achieving HIV cure would have a high impact on their lives, not only from a medical perspective but also on an economic and social level. Working with key populations in my country, I am interested in patient-focused research to understand the perceptions and beliefs of people living with HIV towards cure.

What is your current area of research?

My current area of research is HIV prevention. Since 2017, I have been working with key populations in my country, especially MSM and transgender women, conducting observational studies and participating in a PrEP clinical trial. Currently, I am working at Helios Salud, which is the largest private healthcare institution dedicated to people living with HIV in Argentina. There, I am part of the site team for the HIV vaccine trial HVTN706. Related to this initiative, we are also studying the acceptability of new prevention methods in the community.